Health News Releases

  • Today November 13
July 15, 2015 17:30
Takeda Submits New Drug Application for Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that a New Drug Application (NDA) has been submitted to the United States (U.S.) Food and Drug Administration (FDA) for ixazomib, an i
July 14, 2015 13:10
Masimo Renews its $1,000,000 Performance Guarantee that Masimo SET® Technology Will Outperform All Nellcor™ Pulse Oximeters
Masimo (NASDAQ: MASI), the inventor of measure-through motion and low perfusion pulse oximetry, today renewed its $1,000,000 (USD) performance guarantee that Masimo SET® Pulse Oximetry will outperform
July 07, 2015 09:15
Phase III data published in The Lancet Oncology shows a significant overall survival benefit of Giotrif® (afatinib) compared to Tarceva® (erlotinib)
Phase III data published in The Lancet Oncology shows a significant overall survival benefit of Giotrif® (afatinib) compared to Tarceva® (erlotinib) in patients with previously treated advanced squamo
July 03, 2015 11:45
Quintiles and Quest Diagnostics Launch Q2 Solutions
Quintiles (www.quintiles.com) and Quest Diagnostics (http://goo.gl/NbIXp) today announced the launch of Q2 Solutions (www.q2labsolutions.com), their new combined clinical trials laboratory services or
July 02, 2015 15:25
New advance in COPD maintenance treatment, Spiolto® Respimat®, approved in first European countries
Boehringer Ingelheim today announced regulatory authority approvals for Spiolto® Respimat® (tiotropium/olodaterol) in first European countries†. Spiolto® Respimat® is a once-daily maintenance treatmen
July 01, 2015 11:40
Turkey’s Leading University Hospital Adopts Masimo SpHb for Continuous Noninvasive Haemoglobin Monitoring
Masimo (www.masimo.co.uk) (NASDAQ: MASI) announced today that Turgut Ozal Medical Centre Liver Hospital (http://totm.inonu.edu.tr/index.php) in Malatya, Turkey, has installed Masimo’s noninvasive, con
June 30, 2015 14:00
Cranberry Juice May Help Protect Against Heart Disease and Diabetes Risk Factors
A new study[1] reveals that drinking low-calorie cranberry juice cocktail may help lower the risk of chronic diseases that rank among the leading causes of death worldwide, including heart disease, di
June 25, 2015 10:15
Estima Pharma Solutions LLP Wins CQE Award for Compliance on QC100 Total Quality Management Model Criteria for 2015
Recognized for Commitment to Quality, Excellence, Leadership, Technology and Innovation, Estima Pharma Solutions LLP, India, was presented the CQE Century International Quality ERA Award, for complian
June 25, 2015 02:00
Morinaga Milk Industry: Probiotic Supplementation Causes Fat Loss in Overweight Adults
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), the second largest dairy product company in Japan, confirmed that its new probiotic ingredient, Bifidobacterium breve B-3, caused a significant reduction
June 24, 2015 10:40
Masimo Receives CE Mark for MightySat Rx Pulse Oximeter
Masimo (http://masimo.co.uk) (NASDAQ: MASI) today announced the CE Mark and full market release of MightySat™ Rx fingertip pulse oximeter for clinical use in CE countries, offering the same Masimo SET
June 23, 2015 10:10
Idarucizumab* reverses the anticoagulant effect of dabigatran within minutes in patient study
Results from an interim analysis of the Phase III RE-VERSE AD™ patient study demonstrate that 5 g of idarucizumab* immediately reversed the anticoagulant effect of dabigatran (Pradaxa®) in patients re
June 21, 2015 09:00
Dr. Seo Hyo-seok Gave Lecture on Unique Concepts of Korean Medicine at 2015 World Conference of Science Journalists
Dr. Seo Hyo-seok participated in the ‘2015 World Conference of Science Journalists’ held in COEX, Samsung-dong, Seoul, Korea from the 8th to the 12th in his capacity as a sponsor and explained the con
June 19, 2015 14:40
Gore Global Registry for Endovascular Aortic Treatment Enrolls 3,000 Patients
W. L. Gore & Associates, Inc. (www.goremedical.com) (Gore) announced that important updates from the Gore Global Registry for Endovascular Aortic Treatment (GREAT) will be presented today at the 2015
June 17, 2015 11:55
Cook Group President Kem Hawkins to Retire in July
Cook Group announced today that Kem Hawkins, president of Cook Group Incorporated, will retire on July 1 after 34 years with the Cook organization. Hawkins, who has been transitioning his role in the
June 16, 2015 17:20
New publication in The Lancet describes effective reversal of Pradaxa® in healthy volunteers
Today, The Lancet published results from a healthy volunteer study investigating the reversal of the anticoagulant effect of Pradaxa® (dabigatran etexilate) by its specific reversal agent idarucizumab
June 16, 2015 13:35
Quintiles Unveils New Predictive and Advanced Analytics Capabilities to Enhance its Risk-Based Monitoring Solution
Quintiles, the world’s largest biopharmaceutical services company, today announced the addition of advanced statistical monitoring and predictive analytics capabilities to its risk-based monitoring (R
June 11, 2015 11:45
Bioventus Leaders Promoted to Manage International Business and Expansion
Bioventus® (www.bioventusglobal.com), a leader in orthobiologic solutions, today announced promotions to its executive leadership team. Effective immediately Andrew Hosmer is promoted to Managing Dire
June 10, 2015 09:40
Oral Presentation Evaluating Pooled Data on OTEZLA® (apremilast) for Long-Term Improvements in Enthesitis and Dactylitis to Be Presented at EULAR
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced that the findings from a long-term (104-week) post-hoc analysis of pooled data from the PALA
June 08, 2015 17:50
Type 2 diabetes: Patients reporting better quality of communication by their physician show improved self-care
New research shows that the quality of patient-physician communication, at the moment when additional oral type 2 diabetes (T2D) medication is prescribed (‘add-on’), is linked to future patient self-c
June 08, 2015 17:45
Type 2 diabetes: Empagliflozin/metformin demonstrates reductions in blood glucose in data presented at ADA
A Phase III clinical trial has found that empagliflozin in combination with metformin reduces blood glucose levels in adults with type 2 diabetes (T2D). Boehringer Ingelheim and Eli Lilly and Company
June 08, 2015 11:35
HOYA Group PENTAX Medical Launches Splash M-Knife, the New Multi-Functional ESD Device Contributing in Early Treatment of Gastric Cancer
HOYA Group PENTAX Medical launches Splash M-Knife, the new multi-functional ESD Device to achieve complete Endoscopic Submucosal Dissection (ESD herein after) with a single device. The new device will
June 08, 2015 11:10
Quintiles Officially Opens Greater China Regional Headquarters in Shanghai
More than 30 leaders from China’s government and healthcare communities joined Quintiles executives here today in officially opening the Quintiles Greater China Regional Headquarters, further expandin
June 04, 2015 15:50
Celgene Announces New Data to be Presented at European League Against Rheumatism Annual Congress
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced that data from 11 abstracts (two oral presentations, six poster presentations and three publ
June 03, 2015 18:10
NICE recommends VARGATEF® (nintedanib*) in combination with docetaxel as an option for patients with non-small cell lung cancer of adenocarcinoma histology within its licensed indication
Boehringer Ingelheim today announced that following a review by the National Institute for Health and Care Excellence (NICE) in the UK, VARGATEF® (nintedanib*) in combination with docetaxel has been r
June 03, 2015 14:25
Trophogen, Inc. Announces Signing of Exclusive Global Veterinary License and Purchase Agreement With Zoetis, Inc. for Recombinant Long-Acting and Superactive Bovine Follicle-Stimulating Hormone (rbFSH) Analog for Superovulation in Cows
Trophogen, Inc. today announced that the company has completed a licensing and purchase agreement granting Zoetis, Inc., the leading global animal health company, an exclusive license to develop Troph
25 per page50 per page75 per page100 per page